{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:47:03Z","timestamp":1790718423870,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-0086"],"award-info":[{"award-number":["IIRP-2023-0086"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006464","name":"Birla Institute of Technology and Science, Pilani","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.colsurfb.2026.115459","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:50:14Z","timestamp":1769705414000},"page":"115459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tannic acid-modified graphene oxide nanoplatform incorporating bortezomib as a combination chemo- and NIR-mediated photothermal oral cancer therapy"],"prefix":"10.1016","volume":"262","author":[{"given":"Sneha","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonmoy","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesha","family":"Chanchlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naitik","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1575-4206","authenticated-orcid":false,"given":"Swati","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2026.115459_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116508","article-title":"Nanomaterials-based advanced systems for photothermal \/ photodynamic therapy of oral cancer","volume":"272","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2026.115459_bib2","article-title":"Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer","volume":"49","author":"Vyas","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2026.115459_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/21691401.2017.1373284","article-title":"Application of nanocarrier-based drug delivery system in treatment of oral cancer","volume":"46","author":"Sah","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.colsurfb.2026.115459_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094344","article-title":"Advances in photothermal therapy for oral cancer","volume":"26","author":"Liang","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.115459_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1533034618768637","article-title":"Photothermal effects of reduced graphene oxide on pancreatic cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.colsurfb.2026.115459_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213550","article-title":"Polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancer","volume":"153","author":"Itoo","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.colsurfb.2026.115459_bib7","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2147\/IJN.S287415","article-title":"Graphene oxide theranostic effect: Conjugation of photothermal and photodynamic therapies based on an in vivo demonstration","volume":"16","author":"Romero","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115459_bib8","author":"Han","year":"2020","journal-title":"Review Article Functionalization and optimization-strategy of graphene oxide-based nanomaterials for gene and drug delivery"},{"key":"10.1016\/j.colsurfb.2026.115459_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22062989","article-title":"Functionalized reduced graphene oxide as a versatile tool for cancer therapy","volume":"22","author":"Dash","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.115459_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2022.08.011","article-title":"Multifunctional graphene oxide nanoparticles for drug delivery in cancer","volume":"350","author":"Itoo","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.115459_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jconrel.2023.01.028","article-title":"Graphene oxide nanoarchitectures in cancer biology: nano-modulators of autophagy and apoptosis","volume":"354","author":"Taheriazam","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.115459_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.119104","article-title":"Surface functionalization of graphene oxide with tannic acid: covalent vs non-covalent approaches","volume":"357","author":"Sainz-Urruela","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.colsurfb.2026.115459_bib13","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1039\/D1RA06731A","article-title":"Evolution of graphene oxide (GO)-based nanohybrid materials with diverse compositions: an overview","volume":"12","author":"Majumder","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.colsurfb.2026.115459_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113288","article-title":"Ultrasmall graphene oxide for combination of enhanced chemotherapy and photothermal therapy of breast cancer","volume":"225","author":"Li","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2026.115459_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201968","article-title":"Graphene oxide nanoscale platform enhances the anti-cancer properties of bortezomib in glioblastoma models","volume":"12","author":"Sharp","year":"2023","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.colsurfb.2026.115459_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s40495-020-00211-y","article-title":"Tannic acid: specific form of tannins in cancer chemoprevention and therapy-old and new applications","volume":"6","author":"Baer-Dubowska","year":"2020","journal-title":"Curr. Pharm. Rep."},{"key":"10.1016\/j.colsurfb.2026.115459_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcis.2018.09.072","article-title":"Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells","volume":"535","author":"Chowdhury","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2026.115459_bib18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s12013-024-01286-w","article-title":"Tannic acid impedes the proliferation of bladder cancer cells by elevating mitochondrial pathways of apoptosis","volume":"82","author":"Li","year":"2024","journal-title":"Cell Biochem Biophys."},{"key":"10.1016\/j.colsurfb.2026.115459_bib19","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.31557\/APJCP.2023.24.8.2705","article-title":"Triggering of endoplasmic reticulum stress by tannic acid inhibits the proliferation and migration of colorectal cancer cells","volume":"24","author":"Nejad","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.colsurfb.2026.115459_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40262-018-0679-9","article-title":"Clinical pharmacokinetics and pharmacodynamics of bortezomib","volume":"58","author":"Tan","year":"2018","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115459_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd1159","article-title":"Bortezomib. Market analysis","volume":"2","author":"Paramore","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2026.115459_bib22","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1039\/C9TB02174D","article-title":"Self-assembly and self-delivery nanodrug of bortezomib: a simple approach to achieve the trade-off between functionality and druggability","volume":"7","author":"Zhao","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2026.115459_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0760-0","article-title":"Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation","volume":"37","author":"Wu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.colsurfb.2026.115459_bib24","article-title":"Bortezomib-encapsulated dual responsive copolymeric nanoparticles for gallbladder cancer targeted therapy","volume":"9","author":"Chen","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2026.115459_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123125","article-title":"Bortezomib in cancer therapy: mechanisms, side effects, and future proteasome inhibitors","volume":"358","author":"Sogbein","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.colsurfb.2026.115459_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.03.017","article-title":"Inhibitory effects of bortezomib in a subcutaneous tumor model of H22 mouse hepatocarcinoma cells","volume":"215","author":"Zhu","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.colsurfb.2026.115459_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000463","article-title":"Complete tumor regression by liposomal bortezomib in a humanized mouse model of multiple myeloma","volume":"4","author":"Deshantri","year":"2020","journal-title":"Hemasphere"},{"key":"10.1016\/j.colsurfb.2026.115459_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2867-5-18","article-title":"Preclinical evaluation of the proteasome inhbitor bortezomib in cancer therapy","volume":"5","author":"Boccadoro","year":"2005","journal-title":"Cancer Cell Int."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:31:35Z","timestamp":1774020695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["S0927776526000470"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115459","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tannic acid-modified graphene oxide nanoplatform incorporating bortezomib as a combination chemo- and NIR-mediated photothermal oral cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115459"}}